Patient Registry Software Market Thumbnail Image

2022

Patient Registry Software Market

Patient Registry Software Market Size, Share, Competitive Landscape and Trend Analysis Report by Registry type, by Software type, by Functionality, by End User : Global Opportunity Analysis and Industry Forecast, 2022-2031

LS : Healthcare

Select an option
Author's: Avinash Gadekar | Roshan Deshmukh
Publish Date:

Get Sample to Email

Patient Registry Software Market Research, 2031

The global patient registry software market was valued at $993.3 million in 2021, and is projected to reach $2,508.27 million by 2031, growing at a CAGR of 9.7% from 2022 to 2031. A patient registry is a systematic collection of data about individuals who share a certain disease or condition. Patient registries software can be used to monitor outcomes and study best practices in care or treatment of patients. It may pursue a specific, focused research agenda, collecting data for a limited time to answer a specific research question (or questions), or may collect data on an indefinite basis to answer a variety of existing and emerging research questions. Patient registries are playing an increasingly important role in the health care system. Patient registries can be used for a variety of purposes, including monitoring outcomes, studying best practices, and investigating emerging trends. Although patient registries have been around for many years, the use of electronic health records has made it easier than ever to collect and analyze data. As a result, patient registries are expected to play an even more important role in the years to come. Patient registries have traditionally been researcher-generated. Research institutions, academic clinical institutions, or individual research teams establish a registry, using private or Federal funds, for the purpose of observational data collection that can be used for a specific research agenda. These registries may be organized and operated in a variety of forms and formats. They may be operated by a single institution or by a collaborative of multiple institutions or clinics. Researcher-generated patient registries currently exist for a wide range of chronic or rare conditions, including many forms of cancer, diabetes, cystic fibrosis, acute coronary syndrome, and arthritis.

The growth of patient registry software market size is driven by increase in the usage of electronic health records (EHRs), increase in prevalence of chronic diseases, rise in government support for healthcare, surge in geriatric population and increase in potential benefits of patient registry in hospitals and research organizations.

Patient Registry Software Market

 

Furthermore, the increase in usage of the stored data for post-marketing surveillance and surge in government initiatives to build patient registries helps to increase the patient registry software market growth. However, concerns related to the lack of maintenance of important private data security and privacy of the data and dearth of skilled resources hinder the growth of patient registry software market size. Conversely, the patient registry software market opportunity includes the trend like increase in awareness regarding technologies.

Impact of COVID-19 Pandemic on Patient Registry Software Market

The COVID-19 pandemic affected the patient registry software industry in positive way, like various other medical internet of things (IoT) industries were affected. The rise in the number of COVID-19 patients gave rise to the challenges to the healthcare providers of providing vaccines and products to patients in paralleled manner. The healthcare providers were helped by the registry software to find how many health-related products and vaccines must be needed in a particular area. Moreover, the COVID-19 infection was more prone to the people suffering from chronic respiratory disease, hypertension, cardiovascular disease, diabetes mellitus, and cancer. The administration of COVID-19 medication to these population was harmful for their life. Hence, the healthcare providers took the help of patient registry software to analyze the patient’s condition, and give appropriate medicine to reduce the viral infection. According to the data of Health IT government, the COVID-19 patient registry software allows the number of cases to be managed uniquely across various agencies and organizations. Moreover, the software also supported in nationwide tracking and reporting of infections/immunization. The patient registry software also helped to aggregate the clinical data such as test results and status updates from hospitals, public health departments, labs and physician practices for reporting and tracking of the disease. The patient registry software was also used by the department of Office of the National Coordinator for Health Information Technology (ONC) and American Public Health Association (APHA) as part of the Pandemic Response Hackathon sponsored for studying the data of COVID-19 test results and status in 2020.

Patient Registry Software Market Segmentation

The patient registry software market is segmented into Registry type, Software type, Functionality and End User. On the basis of registry type, the market is divided into disease registry, health service registry and product registry. The disease registry segment is further segmented by type into cardiovascular registry, diabetes registry, cancer registry, rare disease registry and others. The product registry segment is further divided into medical device registry and drug registry. On the basis of software type, the market is classified into standalone and integrated. On the basis of functionality, the market is classified into population health management, health information exchange, patient care management, medical research and clinical studies and others. On the basis of end user, the market is classified into hospitals, government and third party organizations, pharma, biotech and medical device companies and others. Region wise, the market is studied across North America (U.S., Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA).

Market By Registry Type Segment Review

By registry type, the market is classified into disease registry, health service registry and product registry. The disease registry segment is further segmented by type. By type, it is segmented into cardiovascular registry, diabetes registry, cancer registry, rare disease registry and others. The product registry segment is further divided into medical device registry and drug registry. The disease registry segment accounted for the major share of the market in 2021 and is anticipated to continue this trend throughout the forecast period, owing to advantages that are offered by these software and increased adoption of patient registry software.

Patient Registry Software Market
By Registry Type
Your browser does not support the canvas element.

The Disease Registry segment was the highest revenue contributor in 2021 and is expected to remain dominant during the forecast period.

Market By Software Type Segment Review

By software type, the market is classified into standalone and integrated. The integrated segment accounted for the major share of the market in 2021 and is anticipated to continue this trend throughout the forecast period, owing to surge in number of integrated software system adopted in hospitals and rise in prevalence of chronic conditions. Moreover, rise in preference of the cardiovascular diseases and oncology also helps in growth of the patient registry software market share.

Patient Registry Software Market
By Software Type
Your browser does not support the canvas element.

The Integrated segment was the highest revenue contributor in 2021 and is expected to remain dominant during the forecast period.

Market By Functionality Segment Review

By functionality, the market is classified into population health management, health information exchange, patient care management, medical research and clinical studies and others. The population health management segment accounted for the major share of the market in 2021 and is anticipated to continue this trend throughout the forecast period, owing to surge in demand for medical research and clinical studies related to various healthcare issues, which is mainly due to increase in the incidences of various diseases. Moreover, rise in number of hospitals visits also contributes toward growth of the market.

Patient Registry Software Market
By Functionality
Your browser does not support the canvas element.

The Population Health Management segment was the highest revenue contributor in 2021 and is expected to remain dominant during the forecast period.

Market By End User Segment Review

By end user, the market is classified into hospitals, government and third party organizations, pharma, biotech and medical device companies and others. The government and third party organizations segment accounted for the major share of the market in 2021 and is anticipated to continue this trend throughout the forecast period, owing to surge in number of pharmaceutical, biotechnology and medical device companies, which is mainly due to increase in demand of pharmaceutical and biotechnology products.

Patient Registry Software Market
By End User
Your browser does not support the canvas element.

The Government and third party organizations segment was the highest revenue contributor in 2021 and is expected to remain dominant during the forecast period.

Market By Region Review

North America was the dominant region in 2021, and is expected to remain dominant throughout the forecast period, owing to high prevalence rate of chronic diseases, and surge in number of treatment procedures performed in the region. However, Asia-Pacific is expected to witness highest CAGR of 11.3% during the patient registry software market forecast period, owing to presence of high populace countries such as India and China, which increases prevalence rate of chronic diseases, geriatric population, and number of pharmaceutical companies.

Patient Registry Software Market
By Region
2031
North America 
Europe
Asia-Pacific
LAMEA

North America was the highest revenue contributor in 2021 and is expected to remain dominant during the forecast period.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the patient registry software market analysis from 2021 to 2031 to identify the prevailing patient registry software market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the patient registry software market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global patient registry software market trends, key players, market segments, application areas, and market growth strategies.

Patient Registry Software Market Report Highlights

Aspects Details
icon_1
Market Size By 2031

USD 2.5 billion

icon_2
Growth Rate

CAGR of 9.7%

icon_3
Forecast period

2021 - 2031

icon_4
Report Pages

339

icon_5
By Registry type
  • Disease Registry
    • Type
      • Cardiovascular Registry
      • Diabetes Registry
      • Cancer Registry
      • Rare Disease Registry
      • Others
  • Health Service Registry
  • Product Registry
    • Type
      • Medical device Registry
      • Drug Registry
icon_6
By Software type
  • Standalone
  • Integrated
icon_7
By Functionality
  • Population Health Management
  • Health Information Exchange
  • Patient Care Management
  • Medical Research and Clinical Studies
  • Others
icon_8
By End User
  • Hospitals
  • Government and third party organizations
  • Pharma, Biotech and Medical Device Companies
  • Others
icon_9
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest Of Europe)
  • Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest Of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest Of LAMEA)
icon_10
Key Market Players

ImageTrend, Inc., Elekta AB (pub), Optum, Inc., Open Text Corporation., IQVIA Holdings, Dacima Software Inc., Ordinal Data, Inc., Premier, Inc., Conduent, Inc., McKesson Corporation, FIGmd, Inc.

Analyst Review

The patient registries are organized systems that use observational methods to collect uniform data on a population defined by a particular disease, condition or exposure, and that is followed over time. Patient registries can play an important role in monitoring the safety of medicines.

North America was the dominant region in 2021, and is expected to remain dominant throughout the forecast period, owing to high prevalence rate of chronic diseases, and surge in number of treatment procedures performed in the region. However, Asia-Pacific is expected to witness highest CAGR during the analysis period, owing to presence of high populace countries such as India and China, which increases prevalence rate of chronic disease like cardiovascular diseases

Author Name(s) : Avinash Gadekar | Roshan Deshmukh
Frequently Asked Questions?

The key trends of Patient Registry Software Market include the increase in the usage of electronic health records (EHRs), increase in prevalence of chronic diseases, rise in government support for healthcare, surge in geriatric population and increase in potential benefits of patient registry in hospitals and research organizations.

The leading application of patient registry software market is that the patient registry software helps deliver insights from a multi-terabyte database anywhere, anytime, and on any platform, with ease of management.

North America is the largest regional market for patient registry software market.

The estimated industry size of patient registry software market in 2031 is $2,508.27 million.

The top companies to hold the market share in patient registry software Market include Allscripts healthcare solutions, Inc., Elekta Solutions AB, IQVIA Holdings Inc., McKesson Corporation, MRO Corp. (FIGmd, Inc.), Open Text Corporation.

The forecast period in the market report is from 2022 to 2031.

Yes, the patient registry software market report provides PORTER Analysis.

Yes, the patient registry software market companies are profiled in the report.

Loading Table Of Content...

Loading Research Methodology...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Patient Registry Software Market

Global Opportunity Analysis and Industry Forecast, 2022-2031